Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs.

Ashley L Buchanan, Natallia Katenka, Youjin Lee, Jing Wu, Katerina Pantavou, Samuel R Friedman, M Elizabeth Halloran, Brandon D L Marshall, Laura Forastiere, Georgios K Nikolopoulos
Author Information
  1. Ashley L Buchanan: Department of Pharmacy Practice, University of Rhode Island, Kingston, RI 02881, USA. ORCID
  2. Natallia Katenka: Department of Computer Science and Statistics, University of Rhode Island, Kingston, RI 02881, USA.
  3. Youjin Lee: Department of Biostatistics, Brown University, Providence, RI 02912, USA.
  4. Jing Wu: Department of Computer Science and Statistics, University of Rhode Island, Kingston, RI 02881, USA.
  5. Katerina Pantavou: Medical School, University of Cyprus, 1678 Nicosia, Cyprus.
  6. Samuel R Friedman: Department of Population Health, New York University, New York, NY 10016, USA. ORCID
  7. M Elizabeth Halloran: Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. ORCID
  8. Brandon D L Marshall: Department of Epidemiology, Brown University School of Public Health, Providence, RI 02912, USA. ORCID
  9. Laura Forastiere: Department of Biostatistics, Yale School of Public Health, New Haven, CT 06520, USA.
  10. Georgios K Nikolopoulos: Medical School, University of Cyprus, 1678 Nicosia, Cyprus. ORCID

Abstract

Human Immunodeficiency Virus (HIV) interventions among people who use drugs (PWUD) often have spillover, also known as interference or dissemination, which occurs when one participant's exposure affects another participant's outcome. PWUD are often members of networks defined by social, sexual, and drug-use partnerships and their receipt of interventions can affect other members in their network. For example, HIV interventions with possible spillover include educational training about HIV risk reduction, pre-exposure prophylaxis, or treatment as prevention. In turn, intervention effects frequently depend on the network structure, and intervention coverage levels and spillover can occur even if not measured in a study, possibly resulting in an underestimation of intervention effects. Recent methodological approaches were developed to assess spillover in the context of network-based studies. This tutorial provides an overview of different study designs for network-based studies and related methodological approaches for assessing spillover in each design. We also provide an overview of other important methodological issues in network studies, including causal influence in networks and missing data. Finally, we highlight applications of different designs and methods from studies of PWUD and conclude with an illustrative example from the Transmission Reduction Intervention Project (TRIP) in Athens, Greece.

Keywords

References

  1. Addiction. 2015 Sep;110(9):1453-67 [PMID: 26032121]
  2. AIDS Behav. 2017 Apr;21(4):1183-1207 [PMID: 27125244]
  3. Subst Use Misuse. 2021;56(8):1190-1201 [PMID: 33975493]
  4. Stat Methods Med Res. 2021 Sep;30(9):2105-2118 [PMID: 34319832]
  5. AIDS Behav. 2014 Oct;18(10):1821-34 [PMID: 24165983]
  6. Addiction. 2013 May;108(5):934-43 [PMID: 23362861]
  7. Stat Methods Med Res. 2013 Jun;22(3):278-95 [PMID: 21220355]
  8. Health Serv Outcomes Res Methodol. 2008 Dec 1;8(4):222-269 [PMID: 20046802]
  9. Soc Sci Med. 2009 Feb;68(4):740-8 [PMID: 19070413]
  10. BMJ Open. 2021 Sep 2;11(9):e049610 [PMID: 34475172]
  11. Epidemiol Infect. 2017 Jan;145(2):401-412 [PMID: 27780490]
  12. J Stat Softw. 2017;82: [PMID: 29430216]
  13. Lancet. 2010 Jul 24;376(9737):285-301 [PMID: 20650522]
  14. Addict Behav. 2006 Sep;31(9):1607-18 [PMID: 16459023]
  15. Sociol Methods Res. 2011 May;40(2):211-239 [PMID: 22523436]
  16. J R Stat Soc Ser C Appl Stat. 2017 Apr;66(3):501-519 [PMID: 35095118]
  17. Public Health Rep. 1998 Jun;113 Suppl 1:151-9 [PMID: 9722820]
  18. J Int AIDS Soc. 2019 Jun;22(6):e25330 [PMID: 31245917]
  19. Science. 2012 Jul 6;337(6090):49-53 [PMID: 22767921]
  20. Pharm Stat. 2020 Sep;19(5):710-719 [PMID: 32372535]
  21. Clin Infect Dis. 2021 Jun 15;72(12):e959-e969 [PMID: 33165566]
  22. Ann Epidemiol. 2016 Nov;26(11):802-809 [PMID: 28126091]
  23. AIDS Behav. 2017 Oct;21(10):2924-2934 [PMID: 28097618]
  24. Am J Public Health. 1997 Aug;87(8):1289-96 [PMID: 9279263]
  25. Drug Alcohol Depend. 2019 Jan 1;194:453-459 [PMID: 30503906]
  26. Epidemiol Infect. 2019 Jan;147:e173 [PMID: 31063105]
  27. Am J Public Health. 2013 Jan;103(1):e44-52 [PMID: 23153148]
  28. J Causal Inference. 2021 Jan;9(1):9-38 [PMID: 34676152]
  29. Lancet. 2008 Nov 15;372(9651):1733-45 [PMID: 18817968]
  30. Drug Alcohol Depend. 2017 Jun 1;175:164-170 [PMID: 28433895]
  31. Multivariate Behav Res. 2016 Jul-Aug;51(4):495-518 [PMID: 27269278]
  32. Int J Epidemiol. 2023 Feb 8;52(1):107-118 [PMID: 35834775]
  33. Ann Stat. 2021 Apr;49(2):673-701 [PMID: 34421150]
  34. Ann Appl Stat. 2010;4(1):5-25 [PMID: 26561513]
  35. Biostatistics. 2022 Jul 18;23(3):789-806 [PMID: 33528006]
  36. Ann Stat. 2013 Apr;41(2):508-535 [PMID: 26166910]
  37. J Am Stat Assoc. 2008 Jun;103(482):832-842 [PMID: 19081744]
  38. Am J Epidemiol. 2018 Jan 1;187(1):153-160 [PMID: 28605424]
  39. BMJ Open. 2020 Oct 7;10(10):e033759 [PMID: 33033007]
  40. J Am Stat Assoc. 2018;113(522):755-766 [PMID: 30828120]
  41. Lancet. 2010 Jul 31;376(9738):367-87 [PMID: 20650518]
  42. Harm Reduct J. 2018 Nov 12;15(1):55 [PMID: 30419926]
  43. Subst Use Misuse. 2013 Dec;48(14):1485-97 [PMID: 23819740]
  44. Subst Use Misuse. 2009;44(2):253-81 [PMID: 19142824]
  45. Viruses. 2020 Apr 20;12(4): [PMID: 32326127]
  46. J R Stat Soc Ser A Stat Soc. 2020 Oct;183(4):1659-1676 [PMID: 34316102]
  47. PLoS One. 2016 Feb 01;11(2):e0148314 [PMID: 26828362]
  48. Biometrika. 2016 Dec;103(4):829-842 [PMID: 29422692]
  49. AIDS Care. 2019 Nov;31(11):1376-1383 [PMID: 30939897]
  50. Int J Epidemiol. 2019 Aug 1;48(4):1387 [PMID: 31157381]
  51. J Int AIDS Soc. 2018 Jan;21(1): [PMID: 29356365]
  52. Science. 2022 Mar 11;375(6585):1155-1159 [PMID: 35084938]
  53. Biometrics. 2022 Jun;78(2):777-788 [PMID: 33768557]
  54. Sci Rep. 2016 Dec 05;6:38100 [PMID: 27917890]
  55. J Causal Inference. 2016 Nov;5(1): [PMID: 29057197]
  56. Int J Epidemiol. 2018 Feb 1;47(1):332-347 [PMID: 29106568]
  57. Soc Sci Med. 2017 Feb;174:26-34 [PMID: 27987435]
  58. Addiction. 2011 Feb;106(2):366-75 [PMID: 21054614]
  59. J R Stat Soc Ser A Stat Soc. 2015 Jun;178(3):619-639 [PMID: 26640328]
  60. J Am Stat Assoc. 2021;116(534):833-844 [PMID: 34366505]
  61. Am J Epidemiol. 2019 Aug 1;188(8):1407-1409 [PMID: 31094425]
  62. PLoS One. 2015 May 26;10(5):e0125909 [PMID: 26011427]
  63. Stat (Int Stat Inst). 2019;8(1): [PMID: 31440374]
  64. J Math Biol. 2022 Sep 20;85(4):37 [PMID: 36127558]
  65. J Am Stat Assoc. 2024;119(545):597-611 [PMID: 38800714]
  66. Biometrics. 2014 Sep;70(3):731-44 [PMID: 24845800]
  67. Clin Infect Dis. 2019 Oct 30;69(10):1780-1788 [PMID: 30689757]
  68. Ann Appl Stat. 2023 Sep;17(3):2165-2191 [PMID: 38250709]
  69. Am J Prev Med. 2021 Mar;60(3):369-378 [PMID: 33229144]
  70. Drug Alcohol Depend. 1995 Apr;38(1):1-9 [PMID: 7648991]
  71. Soc Sci Med. 2002 Sep;55(5):803-21 [PMID: 12190272]
  72. Curr Epidemiol Rep. 2016 Dec;3(4):297-305 [PMID: 28133589]
  73. AIDS Behav. 2019 May;23(5):1210-1224 [PMID: 30680540]
  74. J Health Soc Behav. 2022 Jun;63(2):191-209 [PMID: 35392693]
  75. Epidemiology. 2017 Jul;28(4):553-561 [PMID: 28346267]
  76. Biometrics. 2019 Sep;75(3):778-787 [PMID: 30859545]
  77. AIDS Behav. 2014 Mar;18(3):505-10 [PMID: 24469223]
  78. Am J Epidemiol. 2018 Nov 1;187(11):2449-2459 [PMID: 30052722]
  79. Health Psychol. 2009 May;28(3):323-9 [PMID: 19450038]
  80. Addict Behav. 2017 Nov;74:106-111 [PMID: 28609723]
  81. AIDS Behav. 2017 Apr;21(4):994-1003 [PMID: 28058567]
  82. Curr HIV/AIDS Rep. 2018 Aug;15(4):324-335 [PMID: 29931468]
  83. Biometrics. 2020 Mar;76(1):235-245 [PMID: 31388990]
  84. AIDS Behav. 2015 Oct;19(10):1818-27 [PMID: 25935214]
  85. Drug Alcohol Depend. 2021 Apr 1;221:108626 [PMID: 33689967]
  86. J Am Stat Assoc. 2014 Jan 1;109(505):288-301 [PMID: 24659836]
  87. J Causal Inference. 2014 Mar;2(1):13-74 [PMID: 26180755]
  88. Int J Drug Policy. 2017 Aug;46:17-27 [PMID: 28577506]
  89. Epidemics. 2021 Mar;34:100426 [PMID: 33341667]
  90. Behav Med. 2015;41(3):90-7 [PMID: 26332926]
  91. Discrete Dyn Nat Soc. 2013 Jan 1;2013:720818 [PMID: 25083120]
  92. Stat Methods Med Res. 2012 Feb;21(1):55-75 [PMID: 21068053]
  93. Int J Environ Res Public Health. 2021 Mar 01;18(5): [PMID: 33804500]
  94. J Urban Health. 2001 Sep;78(3):411-8 [PMID: 11564845]
  95. Lancet HIV. 2016 Oct;3(10):e482-9 [PMID: 27658879]
  96. Addiction. 2007 Nov;102(11):1730-9 [PMID: 17935581]
  97. Soc Sci Med. 1994 Jan;38(1):67-78 [PMID: 8146717]
  98. AIDS. 1998 Aug 20;12(12):1529-36 [PMID: 9727575]
  99. Lancet Glob Health. 2017 Dec;5(12):e1192-e1207 [PMID: 29074409]
  100. Epidemiology. 2012 Sep;23(5):751-61 [PMID: 22828661]
  101. AIDS Res Hum Retroviruses. 2021 Feb;37(2):130-138 [PMID: 33126818]
  102. Int J Drug Policy. 2021 Feb;88:102580 [PMID: 31740175]
  103. Curr HIV/AIDS Rep. 2018 Apr;15(2):113-119 [PMID: 29457200]
  104. Am J Drug Alcohol Abuse. 2019;45(5):460-469 [PMID: 30896982]
  105. Clin Trials. 2022 Aug;19(4):375-379 [PMID: 35510562]
  106. Medicine (Baltimore). 2018 May;97(1S Suppl 1):S9-S15 [PMID: 29794604]
  107. Am J Epidemiol. 2021 May 4;190(5):939-948 [PMID: 33128066]
  108. Soc Sci Med. 2019 Jul;233:229-236 [PMID: 31229909]
  109. J Clin Med. 2021 Mar 12;10(6): [PMID: 33808991]
  110. Stat Sci. 2014 Nov;29(4):687-706 [PMID: 25620841]
  111. Curr HIV/AIDS Rep. 2018 Jun;15(3):283-292 [PMID: 29905915]
  112. Am J Epidemiol. 1991 Feb 15;133(4):323-31 [PMID: 1899778]

Grants

  1. DP2 DA046856/NIDA NIH HHS
  2. R01 AI085073/NIAID NIH HHS
  3. P30 DA011041/NIDA NIH HHS
  4. DP1 DA034989/NIDA NIH HHS

Word Cloud

Created with Highcharts 10.0.0spilloverstudiesHIVinterventionsPWUDnetworksnetworkinterventioneffectsmethodologicalamongpeopledrugsoftenalsoparticipant'smemberscanexamplestudyapproachesnetwork-basedoverviewdifferentdesignsHumanImmunodeficiencyVirususeknowninterferencedisseminationoccursoneexposureaffectsanotheroutcomedefinedsocialsexualdrug-usepartnershipsreceiptaffectpossibleincludeeducationaltrainingriskreductionpre-exposureprophylaxistreatmentpreventionturnfrequentlydependstructurecoveragelevelsoccurevenmeasuredpossiblyresultingunderestimationRecentdevelopedassesscontexttutorialprovidesrelatedassessingdesignprovideimportantissuesincludingcausalinfluencemissingdataFinallyhighlightapplicationsmethodsconcludeillustrativeTransmissionReductionInterventionProjectTRIPAthensGreeceMethodsAssessingSpilloverNetwork-BasedStudiesHIV/AIDSPreventionPeopleUseDrugshumanimmunodeficiencyvirususe/inject

Similar Articles

Cited By